Security key
79400X305
SALARIUS PHARMACEUTICALS INC - COM NEW (SLRX)
CUSIP: 79400X305
Q1 2023 13F Holders as of 31 Mar 2023
- Security type / class
- Equity / COM NEW
- Total 13F shares
- 97,437
- Total 13F value
- $185,991
- Share change
- +24,747
- SEC-reported price per share
- $1.91
- Number of holders
- 11
- Value change
- +$47,215
- Number of buys
- 6
- Number of sells
- 2
Report period
Q1 2023
Institutions
11
Top holders
10
SLRX full security history
Ownership snapshot
Full 13F holder table
Decoy Therapeutics Inc. SEC filings
Decoy Therapeutics Inc. company facts
Broader feeds
Ownership snapshot
Top reported holders of SLRX - SALARIUS PHARMACEUTICALS INC - COM NEW (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
VANGUARD GROUP INC
Disclosed value leader
VANGUARD GROUP INC
Comparable rows
0/8
Latest evidence
31 Dec 2022
13F
Highest disclosed value: $58,375
8 rows are not safely comparable across share classes.
Showing 1-6 of 8 holder rows.
Quick read
VANGUARD GROUP INC has the largest disclosed position value at $58.4K.
0 of 8 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens VANGUARD GROUP INC's linked filing trail.
Disclosed position value
Top 5
VANGUARD GROUP INC
$58.4K
GEODE CAPITAL MANAGEMENT, LLC
$25K
RENAISSANCE TECHNOLOGIES LLC
$25K
OSAIC HOLDINGS, INC.
$2K
UBS Group AG
$366
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 8 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| VANGUARD GROUP INC |
13F
Company
|
—
denominator unverified
|
$58,375
38,154 shares
|
— | 31 Dec 2022 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
—
denominator unverified
|
$25,000
16,523 shares
|
— | 31 Dec 2022 |
| RENAISSANCE TECHNOLOGIES LLC |
13F
Company
|
—
denominator unverified
|
$25,000
16,342 shares
|
— | 31 Dec 2022 |
| OSAIC HOLDINGS, INC. |
13F
Company
|
—
denominator unverified
|
$2,000
1,307 shares
|
— | 31 Dec 2022 |
| UBS Group AG |
13F
Company
|
—
denominator unverified
|
$366
239 shares
|
— | 31 Dec 2022 |
| MORGAN STANLEY |
13F
Company
|
—
denominator unverified
|
$97
63 shares
|
— | 31 Dec 2022 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2023
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
11
Shares
97,437
Rows available
11
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2023 vs Q1 2023 Across Filers
Q1 2023 holders
11
Q1 2023 holders
11
Holder diff
0
| Investor | Q1 2023 Shares | Q1 2023 Shares | Share Diff | Share Chg % | Q1 2023 value | Q1 2023 value | Value change | Value Chg % |
|---|